Haemonetics (HAE) Tops Q3 EPS by 15c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $74.17 --0%
Revenue Growth %: +2.3%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.3%
Financial Fact:
Gross profit: 104.25M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.81, $0.15 better than the analyst estimate of $0.66. Revenue for the quarter came in at $240 million versus the consensus estimate of $225.73 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
- Morgan Stanley Downgrades Sands China Ltd. (1928:HK) (SCHYY) to Equalweight
- Micron Technology (MU) PT Raised to $1,550 at Needham
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
